Preemptive Analgesia With Steroidal and Nonsteroidal Anti-Inflammatory Drugs in Dental Implant Surgeries: A Systematic Review
Abstract
This systematic review aimed to evaluate the efficacy and safety of preemptive analgesia using oral steroidal and nonsteroidal anti-inflammatory drugs (NSAIDs) in adults undergoing dental implant surgery. A comprehensive search was conducted in the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (via PubMed), Excerpta Medica Database (EMBASE), Virtual Health Library (VHL), Web of Science, and other databases with no restrictions on language or publication date. Randomized clinical trials (RCTs) comparing oral steroidal drugs or NSAIDs with placebo or other anti-inflammatory drugs were included. The primary outcomes were postoperative pain, edema, trismus, discomfort, and use of rescue medication. Pairs of reviewers independently extracted data and assessed the risk of bias. Owing to clinical heterogeneity among the included studies, a narrative synthesis was conducted. Seven RCTs (n = 589 patients) evaluated aceclofenac 100 mg (in combination with acetaminophen), dexamethasone 4 mg, dexketoprofen 25 mg, etoricoxib 90 mg, ibuprofen 600 mg, ketorolac 10 mg, meloxicam 15 mg, nimesulide 100 mg, piroxicam 40 mg, and tenoxicam 20 mg. Favorable results have been reported with etoricoxib 90 mg, ibuprofen 600 mg, and nimesulide 100 mg for controlling postoperative pain and discomfort in single-implant procedures. Meloxicam and tenoxicam have demonstrated efficacy in invasive surgeries involving multiple implants and advanced techniques. Some studies have extended…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 589 participants or records.
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.